论文信息 - Frontline flumatinib versus imatinib in patients with chronic myeloid leukemia in chronic phase: Results from the China randomized phase III study. - 字舞流文

Frontline flumatinib versus imatinib in patients with chronic myeloid leukemia in chronic phase: Results from the China randomized phase III study.

J. Gu | Hao Jiang | Jianxiang Wang | Jie Jin | A. Sun | Wanggang Zhang | Yu Hu | Li Liu | Xi Zhang | Yan Li | Bing-cheng Liu | Huanling Zhu | Fengkui Zhang | Yong-hong Guo | Zhang Li | Yanli Zhang | Jiuwei Cui | J. Qiao | Qi-fa Liu | Li Meng